Postoperative Atrial Fibrillation Impacted by Completeness of Coronary Revascularization and Antiplatelet Regimen

Qin Jiang1,2,3, Minghui Xie4, Yalu Yu3

  • 1Department of Cardiac Surgery, Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan, China, samsph.com.

PubMed

Insights

Incomplete revascularization after off-pump coronary artery bypass grafting increases postoperative atrial fibrillation (POAF) risk, especially with clopidogrel. Complete revascularization is associated with lower POAF rates, regardless of antiplatelet choice.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Arrhythmia Research

Background:

  • Postoperative atrial fibrillation (POAF) is a frequent complication following off-pump coronary artery bypass grafting (OPCABG).
  • Both myocardial ischemia and systemic inflammation are key factors in POAF development.
  • POAF is linked to poorer patient outcomes and extended hospital stays.

Purpose of the Study:

  • To examine the combined effect of revascularization completeness and antiplatelet therapy on POAF incidence.
  • To investigate the relationship between coronary revascularization extent and POAF in OPCABG patients.

Main Methods:

  • Retrospective analysis of 505 patients undergoing elective first-time OPCABG.
  • Patients categorized into incomplete revascularization (IR) and complete revascularization (CR) groups.
  • Comparison of POAF incidence, AF burden, inflammatory markers, and hospital stay between groups.

Main Results:

  • POAF incidence was significantly higher in the IR group (39.2%) compared to the CR group (25.1%).
  • The IR group exhibited increased AF burden, higher IL-6 and D-dimer levels, and longer hospital stays.
  • Among patients on clopidogrel, IR was linked to higher POAF rates (42.6% vs. 25.9%), but this association was not observed with ticagrelor.

Conclusions:

  • Incomplete revascularization is a significant risk factor for POAF post-OPCABG, particularly in patients treated with clopidogrel.
  • Complete revascularization may mitigate POAF risk, irrespective of the dual antiplatelet therapy regimen used.
  • The choice of antiplatelet therapy interacts with revascularization completeness in influencing POAF development.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
347
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
404
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
776